OBJECTIVES: We present the novel application of continuous arterial spin-labeling (CASL) magnetic resonance imaging (MRI) for the measurement of calf muscle perfusion in subjects with progressive peripheral arterial disease (PAD). BACKGROUND: Peripheral arterial disease is largely considered to be a disease of conduit vessels. The impact of PAD upon microvascular flow in the end-organ, muscle, remains unknown. Continuous arterial spin-labeling is a noninvasive MRI method capable of measuring microvascular flow and might assist in our understanding of the impact of PAD upon the microvasculature. METHODS: Forty subjects with varying degrees of PAD and 17 age-matched PAD-free subjects were recruited and underwent measurement of the ankle-to-brachial index (ABI) and CASL. Peak hyperemic flow (PHF) and time-to-peak (TTP) were computed and assessed as a function of ABI and calf muscle group. RESULTS: An ABI dependence was found in both PHF (p = 0.04) and TTP (p < 10(-4)). Whereas TTP increased almost immediately with increasing PAD severity, PHF was, in contrast, relatively well preserved until later stages of disease. CONCLUSIONS: The CASL flow measurements correlate with disease state as measured by ABI and demonstrate preserved microvascular flow reserve in the presence of early to intermediate vascular disease.
OBJECTIVES: We present the novel application of continuous arterial spin-labeling (CASL) magnetic resonance imaging (MRI) for the measurement of calf muscle perfusion in subjects with progressive peripheral arterial disease (PAD). BACKGROUND:Peripheral arterial disease is largely considered to be a disease of conduit vessels. The impact of PAD upon microvascular flow in the end-organ, muscle, remains unknown. Continuous arterial spin-labeling is a noninvasive MRI method capable of measuring microvascular flow and might assist in our understanding of the impact of PAD upon the microvasculature. METHODS: Forty subjects with varying degrees of PAD and 17 age-matched PAD-free subjects were recruited and underwent measurement of the ankle-to-brachial index (ABI) and CASL. Peak hyperemic flow (PHF) and time-to-peak (TTP) were computed and assessed as a function of ABI and calf muscle group. RESULTS: An ABI dependence was found in both PHF (p = 0.04) and TTP (p < 10(-4)). Whereas TTP increased almost immediately with increasing PAD severity, PHF was, in contrast, relatively well preserved until later stages of disease. CONCLUSIONS: The CASL flow measurements correlate with disease state as measured by ABI and demonstrate preserved microvascular flow reserve in the presence of early to intermediate vascular disease.
Authors: David C Isbell; Stuart S Berr; Alicia Y Toledano; Frederick H Epstein; Craig H Meyer; Walter J Rogers; Nancy L Harthun; Klaus D Hagspiel; Arthur Weltman; Christopher M Kramer Journal: J Am Coll Cardiol Date: 2006-05-15 Impact factor: 24.094
Authors: Thanjuvar Bragadeesh; Ibrahim Sari; Marco Pascotto; Antonio Micari; Sanjiv Kaul; Jonathan R Lindner Journal: J Am Coll Cardiol Date: 2005-03-01 Impact factor: 24.094
Authors: Richard B Thompson; Ronnier J Aviles; Anthony Z Faranesh; Venkatesh K Raman; Victor Wright; Robert S Balaban; Elliot R McVeigh; Robert J Lederman Journal: Magn Reson Med Date: 2005-08 Impact factor: 4.668
Authors: Wen-Chau Wu; Jiongjiong Wang; John A Detre; Sarah J Ratcliffe; Thomas F Floyd Journal: J Magn Reson Imaging Date: 2008-08 Impact factor: 4.813
Authors: Wen-Chau Wu; Jiongjiong Wang; John A Detre; Felix W Wehrli; Emile Mohler; Sarah J Ratcliffe; Thomas F Floyd Journal: Am J Physiol Heart Circ Physiol Date: 2008-02-29 Impact factor: 4.733
Authors: Robert G Mitchell; Brian D Duscha; Jennifer L Robbins; Shelley I Redfern; Jayer Chung; Daniel R Bensimhon; William E Kraus; William R Hiatt; Judith G Regensteiner; Brian H Annex Journal: Vasc Med Date: 2007-11 Impact factor: 3.239
Authors: Marta Bosch-Marce; Hiroaki Okuyama; Jacob B Wesley; Kakali Sarkar; Hideo Kimura; Ye V Liu; Huafeng Zhang; Marianne Strazza; Sergio Rey; Lindsey Savino; Yi Fu Zhou; Karin R McDonald; Youn Na; Scott Vandiver; Alireza Rabi; Yuval Shaked; Robert Kerbel; Theresa Lavallee; Gregg L Semenza Journal: Circ Res Date: 2007-10-11 Impact factor: 17.367
Authors: Erin K Englund; Michael C Langham; Sarah J Ratcliffe; Molly J Fanning; Felix W Wehrli; Emile R Mohler; Thomas F Floyd Journal: Circ Cardiovasc Imaging Date: 2015-04 Impact factor: 7.792
Authors: Gerd Brunner; Jean Bismuth; Vijay Nambi; Christie M Ballantyne; Addison A Taylor; Alan B Lumsden; Joel D Morrisett; Dipan J Shah Journal: Med Biol Eng Comput Date: 2016-02-23 Impact factor: 2.602
Authors: Amy M West; Justin D Anderson; Frederick H Epstein; Craig H Meyer; Klaus D Hagspiel; Stuart S Berr; Nancy L Harthun; Arthur L Weltman; Brian H Annex; Christopher M Kramer Journal: Vasc Med Date: 2012-02 Impact factor: 3.239
Authors: Amy M West; Justin D Anderson; Frederick H Epstein; Craig H Meyer; Hongkun Wang; Klaus D Hagspiel; Stuart S Berr; Nancy L Harthun; Arthur L Weltman; Joseph M Dimaria; Jennifer R Hunter; John M Christopher; Christopher M Kramer Journal: J Am Coll Cardiol Date: 2011-08-30 Impact factor: 24.094
Authors: Amy W Pollak; Craig H Meyer; Frederick H Epstein; Ronny S Jiji; Jennifer R Hunter; Joseph M Dimaria; John M Christopher; Christopher M Kramer Journal: JACC Cardiovasc Imaging Date: 2012-12
Authors: Masoud Edalati; Mary K Hastings; David Muccigrosso; Christopher J Sorensen; Charles Hildebolt; Mohamed A Zayed; Michael J Mueller; Jie Zheng Journal: J Magn Reson Imaging Date: 2018-11-16 Impact factor: 4.813